With the success news of the new drug, Ocrelizumab, for primary progressive MS, I wondered, “What’s new for relapsing remitting MS?” Turns out there are many drugs for all the flavors of multiple sclerosis in the works. Check out the MS Society’s page – https://www.mssociety.org.uk/ms-research/treatments-in-the-pipeline to learn what the future may have in store for you.